Everolimus in Pancreatic Neuroendocrine Tumors and Carcinoid Tumors

0 Views
administrator
administrator
07/09/23

Jonathan R. Strosberg, MD; James C. Yao, MD; and Matthew H. Kulke, MD, discuss the role of everolimus, an mTOR inhibitor, in the management of neuroendocrine tumors (NETs).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next